Reducing sitting time and increasing daily activity during cancer treatment
Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
This project will try a digital self-management program plus physiotherapist support to help people with breast, prostate, or colorectal cancer who are starting neo- or adjuvant treatment sit less and feel better during and after treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 172 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mälardalen University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (Uppsala and 1 other locations) |
| Trial ID | NCT06719206 on ClinicalTrials.gov |
What this trial studies
This multicenter randomized controlled study tests a digital self-management program developed with patients to reduce sedentary behavior during ongoing neo- or adjuvant treatment for breast, prostate, or colorectal cancer. Participants use existing goal-setting technology and receive physiotherapist support to choose activities that replace time spent sitting. The trial measures objectively recorded sedentary time, patient-reported well-being, and includes health-economic and climate-benefit analyses. Recruitment takes place at hospitals in Uppsala and Västerås, Sweden with short- and long-term follow-up.
Who should consider this trial
Good fit: Adults with breast, prostate, or colorectal cancer who are planned for or recently started neo- or adjuvant treatment at participating hospitals in Uppsala or Västerås, who can walk independently and use digital tools, are the intended participants.
Not a fit: Patients with dementia, severe psychiatric disease, severe vision or communication impairments, inability to walk independently, or those recently treated for another cancer are excluded and unlikely to benefit from this intervention.
Why it matters
Potential benefit: If effective, the intervention could help patients spend less time sitting during treatment, improve short-term well-being, and lower long-term risks such as treatment-related cardiovascular complications.
How similar studies have performed: Previous smaller trials and pilot studies suggest digital coaching and physiotherapist-supported programs can reduce sedentary time and improve quality of life in cancer patients, but large randomized multicenter evidence is still limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals diagnosed with breast, prostate, or colorectal cancer planned for or resently started neo- or adjuvant treatment (e.g. chemotherapy, radiotherapy, endocrine treatment) at the hospitals in Uppsala and Västerås, Sweden. Exclusion Criteria: * Individuals diagnosed with dementia. * Individuals diagnosed with severe psychiatric disease. * Individuals with severe loss of vision, or communicative ability. * Individuals who cannot walk independently indoors with or without a walking aid. * Individuals completed treatment for other cancer diseases less than 12 months ago or not recovered from previous cancer treatment.
Where this trial is running
Uppsala and 1 other locations
- Akademiska sjukhuset — Uppsala, Sweden (Recruiting)
- Västmanlands sjukhus — Västerås, Sweden (Recruiting)
Study contacts
- Principal investigator: Petra von Heideken Wågert, Professor — Mälardalen University
- Study coordinator: Petra von Heideken Wågert, Professor
- Email: petra.heideken.wagert@mdu.se
- Phone: +46 (0)21-10 3188
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.